Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials.
about
Anticoagulants for acute ischaemic strokeAssociation of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA.Anticoagulation in acute ischemic stroke: A systematic search.Factors associated with recurrent stroke and recanalization in patients presenting with isolated symptomatic carotid occlusionUsing internally developed risk models to assess heterogeneity in treatment effects in clinical trialsIntracranial atherosclerosis: current understanding and perspectivesUse of Heparin in Acute Ischemic Stroke: Is There Still a Role?Does personalized medicine exist and can you test it in a clinical trial?Current and future perspectives on the treatment of cerebral ischemia.New frontiers in anticoagulation: non vitamin-K oral anticoagulants in stroke prevention.Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation.Authors' reply to Finsterer and Aliyev.Rationale and design of Triple AXEL: trial for early anticoagulation in acute ischemic stroke patients with nonvalvular atrial fibrillation.
P2860
Q24187310-0E160E11-FA1D-42D8-A298-DEEC18AEFBF8Q35335927-6980EED1-AB98-4932-9144-CBDA50F8125FQ36287614-19B046E0-F1D0-49D2-AD1A-4075D11A5FB2Q37308886-75AB04C4-8CCC-44AE-99A2-F738DCD507BCQ37642390-1497A579-3394-4794-9ADB-68F6826CEF45Q38205224-8AAE1AFA-76E9-4525-B525-F8D20AF6D826Q38550913-DF3C4582-F7BA-4DF5-874F-8A679209B760Q38568617-CFDAA512-482E-46C2-ACB8-2739E750FCA1Q38732640-31063A41-5EFA-4AC6-B6BF-F9E14034232AQ39027027-0100A126-1A68-4350-A7CA-D9BDF7CD761BQ39665918-82FBB91D-33E1-4333-941B-17DFBD6EA532Q43198488-08C2E0F5-A6CD-4169-B439-0E6EFA8A5470Q51039938-58C47B85-F402-42F7-B502-E144D133D45F
P2860
Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Targeted use of heparin, hepar ...... randomised controlled trials.
@ast
Targeted use of heparin, hepar ...... randomised controlled trials.
@en
type
label
Targeted use of heparin, hepar ...... randomised controlled trials.
@ast
Targeted use of heparin, hepar ...... randomised controlled trials.
@en
prefLabel
Targeted use of heparin, hepar ...... randomised controlled trials.
@ast
Targeted use of heparin, hepar ...... randomised controlled trials.
@en
P2093
P2860
P50
P1433
P1476
Targeted use of heparin, hepar ...... randomised controlled trials.
@en
P2093
Eivind Berge
Harold P Adams
Ka-Sing Lawrence Wong
Martin Dennis
Peter A G Sandercock
P2860
P304
P356
10.1016/S1474-4422(13)70079-6
P577
2013-05-02T00:00:00Z